您已经添加该商品到您的收藏列表
从您收藏列表中删除此商品。
这家公司已成功添加。 查看我的收藏.
这家公司已从你的收藏夹列表中删除。
这家公司已被添加到您的询问车。
这家公司已从询价车中删除。
该商品已被添加到您的询问车。
该商品已经从您的询价车中删除。
商品/公司已达到添加至询价车的数量。
登入NEWPAGES
保持登入状态
每日登录奖励

恭喜! 你获得了今天的每日登录奖励!

5 NP Point这是您获得的奖励!
查看您的每日登录奖励

确保每天回来登入以获更多的奖励!
谢谢!

Back
Seni Jaya Logo
DNA Laboratories Sdn Bhd
DNA Laboratories Sdn Bhd (736763-T)
访客

Cervical Cancer Screening

23-Jan-2017
Cervical Cancer Screening
标签:
-
产品已浏览 353
Cervical Cancer Screening:
Cervical cancer occurs when abnormal cells on the cervix grow out of control. This results in an excessive accumulation of cells which eventually form a lump - a tumor. Cervical cancer can often be successfully treated when it’s found early. It is the third most common cancer among Malaysian women. 
 

Most women diagnosed with cervical cancer are those who screens irregularly or have never been screened for it. Human Papillomavirus (HPV) is the main cause of cervical cancer. It is known to cause cell changes in the cervix and may lead to the development of cervical cancer.

How to prevent cervical cancer:
Cervical cancer can be prevented by undergoing regular screening through co-testing of Liquid Based-Cytology (LBC) and HPV DNA Genotyping Test.













 












 

HPV DNA Test
- HPV DNA Test is a test to detect and determine     the Human Papillomavirus (HPV) strain which is       the main cause of cervical cancer.
- The test enables early detection of cervical cancer
by detecting the presence of HPV even before cell   changes in the cervix have occurre

 

Liquid Based Cytology (LBC)
-  Liquid-Based Cytology (LBC) is the new cervical   cell collection technique developed from the
conventional method, the Pap smear.
-  LBC screens for cell changes or the presence
of abnormal or pre-cancerous cells that can be         effectively treated to prevent cervical cancer

 

The Advantages of Combined LBC + HPV DNA Test:
• Better detection
Co-testing increased the detection of cervical cancer

• Better management
If tested positive for HPV but LBC indicates no cell changes, condition can be closely monitored.

• Cost effective
Co-testing using the combination of cytology plus HPV DNA testing is the appropriate screening for women >30 years old. If tested negative for both tests, the screening interval is no sooner than 3 years            
subsequently. (NCCN Guidelines Version 1.2011 Cervical Cancer Screening)


Frequently Asked Question (FAQ):
1. What are the risk factors for cervical cancer?
   - Sexually active
   - Early onset of sexual activities
   - Multiple sex partner
   - Sexually transmitted disease

2. I have been vaccinated with HPV vacine. Do i still need to go for screening?
   - Yes. Commercially available vaccine only provides 70% protection against the high-risk HPV that  
     can cause cervical cancer.  



Find out more about other tests in this category:
•  Ovarian Cancer Screening
•  Breast Cancer Screening
•  FemCheck

发信息至 DNA Laboratories Sdn Bhd

谢谢您的询问!
我们的客服会尽快联络您。

如需咨询或问题,联系我们
总办事处

DNA Laboratories Sdn Bhd (736763-T)
B1-3 & B1-4, Block Plasma, UKM-MTDC Technology Centre, Universiti Kebangsaan Malaysia, 43650 Bangi, Selangor, Malaysia.
Google Maps Waze

电话: +603-8925 2700
传真: +603-8925 4700

邮件: info@dna-laboratories.com
网址: https://www.dna-laboratories.com
网址: https://dna-laboratories.newpages.com.my/
网址: http://dna-laboratories.n.my/

Powered by NEWPAGES